Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8133491 | 0.86 | ALDH1A1 (0.30) | TSHRALDH1A1TDP1 | |
| SCHEMBL4283771 | 0.83 | PDK1 (0.30) | — | |
| SCHEMBL1503381 | 0.80 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL49872 | 0.80 | ALDH1A1 (0.32) | TSHRALDH1A1TDP1 | |
| SCHEMBL4799337 | 0.79 | CYP2C19 (0.38) | TSHRALDH1A1 | |
| SCHEMBL4283774 | 0.79 | PDK1 (0.30) | — | |
| SCHEMBL2479302 | 0.79 | HSD11B1 (0.39) | — | |
| SCHEMBL19405600 | 0.78 | TAAR1 (0.30) | — | |
| SCHEMBL9214276 | 0.78 | — | — | |
| SCHEMBL454837 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0328643-B1 | (alpha)-HYDROPEROXYISOPROPYLPHENYL COMPOUNDS AND PROCESS FOR THEIR PREPARATION | TERUMO CORP (JP) | 1994-07-06 | — | — | EP | claimed |
| US-5043142-A | Measuring peroxide-active substances | TERUMO KABUSHIKI KAISHA (JP) | 1991-08-27 | — | — | US | claimed |
| EP-0328643-A1 | (alpha)-HYDROPEROXYISOPROPYLPHENYL COMPOUNDS AND PROCESS FOR THEIR PREPARATION | TERUMO KABUSHIKI KAISHA (JP) | 1989-08-23 | — | — | EP | claimed |
| JP-63274867-A | — | — | None | — | — | JP | disclosed |
| JP-63274868-A | — | — | None | — | — | JP | disclosed |
| JP-63275559-A | — | — | None | — | — | JP | disclosed |
| US-20230149221-A1 | WOUND DRESSING | SCAPA UK LIMITED (GB) | 2023-05-18 | — | — | US | disclosed |
| EP-3672543-B1 | WOUND DRESSING | SCAPA UK LTD (GB) | 2022-03-02 | — | — | EP | disclosed |
| US-20210361492-A1 | WOUND DRESSING | SCAPA UK LIMITED (GB) | 2021-11-25 | — | — | US | disclosed |
| EP-3145556-B1 | APERTURED HYDROGEL COMPOSITIONS AND WOUND DRESSINGS | FIRST WATER LTD (GB) | 2020-11-18 | — | — | EP | disclosed |
| US-20200354354-A1 | BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2020-11-12 | — | — | US | disclosed |
| EP-0328643-B1 | (alpha)-HYDROPEROXYISOPROPYLPHENYL COMPOUNDS AND PROCESS FOR THEIR PREPARATION | TERUMO CORP (JP) | 1994-07-06 | — | — | EP | disclosed |
| US-5043142-A | Measuring peroxide-active substances | TERUMO KABUSHIKI KAISHA (JP) | 1991-08-27 | — | — | US | disclosed |
| US-4906662-A | Phenol derivatives, their preparation and the use thereof | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1990-03-06 | — | — | US | disclosed |
| EP-0328643-A1 | (alpha)-HYDROPEROXYISOPROPYLPHENYL COMPOUNDS AND PROCESS FOR THEIR PREPARATION | TERUMO KABUSHIKI KAISHA (JP) | 1989-08-23 | — | — | EP | disclosed |
| JP-S63275559-A | POLY(ALPHA-HYDROPEROXYISOPROPYLPHENYL) COMPOUND AND PRODUCTION THEREOF | TERUMO CORP | 1988-11-14 | — | — | JP | disclosed |
| JP-S63274867-A | TEST COMPOSITION FOR MEASURING PEROXIDE ACTIVATING MATERIAL AND TESTING IMPLEMENT DEPOSITED THEREWITH | TERUMO CORP | 1988-11-11 | — | — | JP | disclosed |
| JP-S63274868-A | ALPHA-HYDROPEROXYISOPROPYL PHENYL COMPOUND AND ITS PRODUCTION | TERUMO CORP | 1988-11-11 | — | — | JP | disclosed |
| US-4745176-A | FRIEDEL-CRAFTS ALKYLATION | BAYER AKTIENGESELLSCHAFT (DE) | 1988-05-17 | — | — | US | disclosed |
| EP-0263229-A1 | Phenol derivatives, their preparation and the use thereof | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1988-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354354-A1 | BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | SCN1A, SCN1B, SCN2B | TSHR 3451/4885ALDH1A1 2797/4885TDP1 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.